Ray Dalio's GH Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 4,010 shares of Guardant Health, Inc. (GH) worth $250,545, representing 0.00% of the portfolio. First purchased in 2020-Q3, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in GH, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2024, adding 72,699 shares. Largest reduction occurred in Q1 2023, reducing 93,111 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Guardant Health (GH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Guardant Health (GH) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2020 | +23,871 | New Buy | 23,871 | $111.77 |
| Q4 2020 | +32,496 | Add 136.13% | 56,367 | $128.89 |
| Q1 2021 | +10,279 | Add 18.24% | 66,646 | $152.66 |
| Q2 2021 | +42,114 | Add 63.19% | 108,760 | $124.19 |
| Q3 2021 | -4,802 | Reduce 4.42% | 103,958 | $125.01 |
| Q4 2021 | +1,195 | Add 1.15% | 105,153 | $100.02 |
| Q1 2022 | +37,888 | Add 36.03% | 143,041 | $66.24 |
| Q2 2022 | +19,437 | Add 13.59% | 162,478 | $40.34 |
| Q3 2022 | -3,015 | Reduce 1.86% | 159,463 | $53.83 |
| Q4 2022 | -30,917 | Reduce 19.39% | 128,546 | $27.20 |
| Q1 2023 | -93,111 | Reduce 72.43% | 35,435 | $23.44 |
| Q2 2023 | -86 | Reduce 0.24% | 35,349 | $35.80 |
| Q3 2023 | +1,675 | Add 4.74% | 37,024 | $29.64 |
| Q4 2023 | -1,907 | Reduce 5.15% | 35,117 | $27.05 |
| Q1 2024 | +72,699 | Add 207.02% | 107,816 | $20.63 |
| Q2 2024 | -87,615 | Reduce 81.26% | 20,201 | $28.88 |
| Q3 2024 | -2,061 | Reduce 10.20% | 18,140 | $22.94 |
| Q4 2024 | -5,596 | Reduce 30.85% | 12,544 | $30.55 |
| Q1 2025 | -7,474 | Reduce 59.58% | 5,070 | $42.60 |
| Q2 2025 | -1,200 | Reduce 23.67% | 3,870 | $52.04 |
| Q3 2025 | +140 | Add 3.62% | 4,010 | $62.48 |
Ray Dalio's Guardant Health Investment FAQs
Ray Dalio first purchased Guardant Health, Inc. (GH) in Q3 2020, acquiring 23,871 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Guardant Health, Inc. (GH) for 21 quarters since Q3 2020. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to Guardant Health, Inc. (GH) was in Q1 2024, adding 107,816 shares worth $2.22 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 4,010 shares of Guardant Health, Inc. (GH), valued at approximately $250,545. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Guardant Health, Inc. (GH) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in Guardant Health, Inc. (GH) was 162,478 shares, as reported at the end of Q2 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.